Transforming	VBG
Growth	NN
Factor	NN
(	(
TGF	NN
)	)
-	:
b	NN
Promotes	VBZ
de	IN
Novo	NNP
Serine	NNP
Synthesis	NN
for	IN
Collagen	NNP
Production	NNP
.	.

TGF-b	NN
promotes	VBZ
excessive	JJ
collagen	NN
deposition	NN
in	IN
fibrotic	JJ
diseases	NNS
such	JJ
as	IN
idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
.	.

The	DT
amino	NN
acid	NN
composition	NN
of	IN
collagen	NN
is	VBZ
unique	JJ
due	JJ
to	TO
its	PRP$
high	JJ
(	(
33	CD
%	NN
)	)
glycine	NN
content	NN
.	.

Here	RB
,	,
we	PRP
report	VBP
that	IN
TGF-b	NN
induces	VBZ
expression	NN
of	IN
glycolytic	JJ
genes	NNS
and	CC
increases	VBZ
glycolytic	JJ
flux	NN
.	.

TGF-b	NN
also	RB
induces	VBZ
the	DT
expression	NN
of	IN
the	DT
enzymes	NNS
of	IN
the	DT
de	FW
novo	FW
serine	NN
synthesis	NN
pathway	NN
(	(
phosphoglycerate-dehydrogenase	NN
(	(
PHGDH	NN
)	)
,	,
phosphoserine	NN
aminotransferase	NN
1	CD
(	(
PSAT1	NN
)	)
,	,
and	CC
phosphoserine	NN
phosphatase	NN
(	(
PSPH	NN
)	)
)	)
and	CC
de	FW
novo	FW
glycine	NN
synthesis	NN
(	(
serine	NN
hydroxymethyltransferase	NN
2	CD
(	(
SHMT2	NN
)	)
)	)
.	.

Studies	NNS
in	IN
fibroblasts	NNS
with	IN
genetic	JJ
attenuation	NN
of	IN
PHGDH	NN
or	CC
SHMT2	NN
and	CC
pharmacologic	JJ
inhibition	NN
of	IN
PHGDH	NN
showed	VBD
that	IN
these	DT
enzymes	NNS
are	VBP
required	VBN
for	IN
collagen	NN
synthesis	NN
.	.

Furthermore	RB
,	,
metabolic	JJ
labeling	NN
experiments	NNS
demonstrated	VBD
carbon	NN
from	IN
glucose	NN
incorporated	VBN
into	IN
collagen	NN
.	.

Lungs	NNS
from	IN
humans	NNS
with	IN
IPF	NN
demonstrated	VBD
increased	VBN
expression	NN
of	IN
PHGDH	NN
and	CC
SHMT2	NN
.	.

These	DT
results	NNS
indicate	VBP
that	IN
the	DT
de	FW
novo	FW
serine	NN
synthesis	NN
pathway	NN
is	VBZ
necessary	JJ
for	IN
TGF-b-induced	JJ
collagen	NN
production	NN
and	CC
suggest	VBP
that	IN
this	DT
pathway	NN
may	MD
be	VB
a	DT
therapeutic	JJ
target	NN
for	IN
treatment	NN
of	IN
fibrotic	JJ
diseases	NNS
including	VBG
IPF	NN
.	.

